Stock INSM INSMED INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

All News Insmed Incorporated

Equities

INSM

US4576693075

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-18 pm EDT 		5-day change 1st Jan Change
24.8 USD -5.27% Intraday chart for Insmed Incorporated -13.17% -19.97%
Apr. 11 Barclays Adjusts Price Target on Insmed to $40 From $37, Maintains Overweight Rating MT
Mar. 27 Insmed Incorporated to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Barclays Adjusts Price Target on Insmed to $40 From $37, Maintains Overweight Rating
MT
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4)
AQ
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR
Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
AQ
Insmed Incorporated to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference
CI
Transcript : Insmed Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 04:35 PM
Insmed Reports Inducement Grants under NASDAQ Listing Rule 5635(4)
AQ
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
PR
Actress Jane Seymour and Insmed Raise Awareness of 'Unseenism' and Empower People to Speak Up When It Comes to Their Health
AQ
Insmed To Present at Three March Conferences
PR
Actress Jane Seymour and Insmed Raise Awareness of "Unseenism" and Empower People to Speak Up When It Comes to Their Health
PR
UBS Initiates Coverage on Insmed With Buy Rating, $46 Price Target
MT
Transcript : Insmed Incorporated, Q4 2023 Earnings Call, Feb 22, 2024
Insmed's Q4 Loss Widens, Revenue Rises
MT
Insmed: Q4 Earnings Snapshot
AQ
Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update
PR
Insmed Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Insmed Incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Insmed Incorporated Reiterates Sales Guidance for the Full-Year 2024
CI
Wolfe Research Starts Insmed With Outperform Rating, $42 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INSM Stock
  4. News Insmed Incorporated